MICROBOT MEDICAL INC. - COMMON STOCK

0,9461

01-ноября-24 15:45:16

15 мин. задержка

Акции

-0,0087

-0,91%

Сегодняшний диапазон

0,9400 - 0,9850

ISIN

N/A

Источник

NASDAQ

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

15 окт 2024 08:38:00 Источник Nasdaq GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

30 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

17 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

22 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

13 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

01 авг 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

18 июл 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

09 июл 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

08 июл 2024 08:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

03 июл 2024 08:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

20 июн 2024 08:25:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

17 июн 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

04 июн 2024 16:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

03 июн 2024 12:11:00 Источник Nasdaq GlobeNewswire
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

03 июн 2024 08:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

29 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Shares Status Following Recent Geopolitical Events

15 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

05 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

30 янв 2024 07:20:00 Источник Nasdaq GlobeNewswire
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

18 янв 2024 07:20:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.